Representatives of different European institutions have given "their clearest signal to date that the fight against Alzheimer's disease and other forms of dementia would feature prominently in the plans of the European institutions in 2008," according to Alzheimer Europe at a meeting in Brussels, Belgium, which was hosted by the French Member of the European Parliament Francoise Grossetete, who is also the chairperson of the European Alzheimer's Alliance.
The event was arranged to coincide with the launch of Alzheimer Europe's second "Dementia in Europe Yearbook" dedicated to a presentation of the social support provided by governments to people with AD in different European countries. Vladimir Spidla, European Commissioner for Employment, Social Affairs and Equal Opportunities, congratulated Alzheimer Europe on emphasizing the social impact of the disease and other forms of dementia on people diagnosed, as well as on their families and carers.
Jean Georges, executive director of Alzheimer Europe, said: "at this meeting, we heard the clearest signal yet that our campaign to make dementia a European public health priority is bearing fruit.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze